Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Terazosin Repurposing Study in ALS (TRUST)

Terazosin RepUrposing STudy in ALS (TRUST) is a single-centre, open-label, biomarker-led proof-of-concept study, funded by the My Name’5 Doddie Foundation, to assess the neuroprotective effects of terazosin in patients with ALS.

Recruitment is now complete. Results will be available in early 2025.